|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/68 | (2018.01) |
| C12Q 1/6886 | (2013.01) | ||
| C12Q2600/178 | (2013.01) |
| (11) | Patento numeris | 2971094 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14717922.0 |
| Europos patento paraiškos padavimo data | 2014-03-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-01-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-09-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/024128 |
| Data | 2014-03-12 |
| (87) | Numeris | WO 2014/150751 |
| Data | 2014-09-25 |
| (30) | Numeris | Data | Šalis |
| 201361791945 P | 2013-03-15 | US | |
| 201361846178 P | 2013-07-15 | US |
| (72) |
JAGANI, Zainab , US
HOFFMAN, Gregory , US
STEGMEIER, Frank , US
MICKANIN, Craig , US
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | BIOMARKERS ASSOCIATED WITH BRM INHIBITION |
| BIOMARKERS ASSOCIATED WITH BRM INHIBITION |